Since short-term exposure to verapamil inhibited transient weakness and myotonia ex vivo in CaV1.1Δe29 ClC-1–/– muscles, we sought to determine whether long-term administration in vivo would improve survival and muscle function in bi-channelopathy mice. The gene discussed is CLCN1; the disease is Myotonia.